• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1蛋白酶的亲和纯化

Affinity purification of the HIV-1 protease.

作者信息

Heimbach J C, Garsky V M, Michelson S R, Dixon R A, Sigal I S, Darke P L

机构信息

Department of Molecular Biology, Merck Sharp and Dohme Research Laboratories, West Point, PA 19486.

出版信息

Biochem Biophys Res Commun. 1989 Nov 15;164(3):955-60. doi: 10.1016/0006-291x(89)91762-2.

DOI:10.1016/0006-291x(89)91762-2
PMID:2686642
Abstract

An inhibitor of the HIV-1 protease has been employed in the generation of a resin which allows the rapid purification of this enzyme. A peptide substrate analogue, H2N-Ser-Gln-Asn-(Phe-psi[CH2N]-Pro)-Ile-Val-Gln-OH, was coupled to agarose resin. The HIV-1 protease was expressed in E. coli and the supernatant from lysed cells was passed through the affinity resin. Active HIV-1 protease was then eluted with a buffer change to pH 10 and 2 M NaCl. Final purification to a homogeneous preparation, capable of crystallization, was achieved with hydrophobic interaction chromatography. Solutions containing HIV-1 protease bound to competitive inhibitors do not bind to the column.

摘要

一种HIV-1蛋白酶抑制剂已被用于生成一种树脂,该树脂可实现对这种酶的快速纯化。一种肽底物类似物H2N-Ser-Gln-Asn-(Phe-ψ[CH2N]-Pro)-Ile-Val-Gln-OH与琼脂糖树脂偶联。HIV-1蛋白酶在大肠杆菌中表达,裂解细胞后的上清液通过亲和树脂。然后通过将缓冲液的pH值变为10并加入2 M NaCl来洗脱活性HIV-1蛋白酶。通过疏水相互作用色谱法最终纯化得到了能够结晶的均一制剂。含有与竞争性抑制剂结合的HIV-1蛋白酶的溶液不会与柱子结合。

相似文献

1
Affinity purification of the HIV-1 protease.HIV-1蛋白酶的亲和纯化
Biochem Biophys Res Commun. 1989 Nov 15;164(3):955-60. doi: 10.1016/0006-291x(89)91762-2.
2
Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.纯化重组HIV-1蛋白酶的底物类似物抑制和活性位点滴定
Biochemistry. 1990 Jan 9;29(1):264-9. doi: 10.1021/bi00453a036.
3
Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose.
Biochem Biophys Res Commun. 1990 Aug 31;171(1):60-6. doi: 10.1016/0006-291x(90)91356-w.
4
Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.1型和2型人类免疫缺陷病毒蛋白酶的特异性与抑制作用
J Biol Chem. 1990 Aug 25;265(24):14675-83.
5
Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography.
FEBS Lett. 1991 Mar 25;280(2):347-50. doi: 10.1016/0014-5793(91)80328-z.
6
Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli.在大肠杆菌中表达的小鼠乳腺肿瘤病毒蛋白酶的纯化与鉴定
J Biol Chem. 1992 Nov 25;267(33):24134-9.
7
Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
Biochem Biophys Res Commun. 1990 May 31;169(1):310-4. doi: 10.1016/0006-291x(90)91469-9.
8
Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli.从病毒pol基因在大肠杆菌中的表达获得的可结晶的HIV-1蛋白酶。
Biochem Biophys Res Commun. 1989 Dec 29;165(3):1043-50. doi: 10.1016/0006-291x(89)92707-1.
9
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.在大肠杆菌中表达的人类免疫缺陷病毒1型蛋白酶表现为二聚体天冬氨酸蛋白酶。
Proc Natl Acad Sci U S A. 1989 Mar;86(6):1841-5. doi: 10.1073/pnas.86.6.1841.
10
Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.gag p17 - p24的P2'位点的替换会影响HIV - 1蛋白酶的切割效率。
Biochem Biophys Res Commun. 1990 Mar 16;167(2):554-60. doi: 10.1016/0006-291x(90)92060-d.

引用本文的文献

1
3'-Tetrahydrofuranylglycine as a Novel, Unnatural Amino Acid Surrogate for Asparagine in the Design of Inhibitors of the HIV Protease.3'-四氢呋喃基甘氨酸作为一种新型非天然氨基酸替代物用于设计HIV蛋白酶抑制剂中的天冬酰胺。
J Am Chem Soc. 1993 Jan 1;115(2):801-803. doi: 10.1021/ja00055a069.
2
Potent HIV-1 Protease Inhibitors: Stereoselective Synthesis of a Dipeptide Mimic.强效HIV-1蛋白酶抑制剂:二肽模拟物的立体选择性合成
J Org Chem. 1993 Feb;58(5):1025-1029. doi: 10.1021/jo00057a011.
3
CYCLIC SULFONE-3-CARBOXAMIDES AS NOVEL P-LIGANDS FOR Ro 31-8959 BASED HIV-1 PROTEASE INHIBITORS.
环状砜-3-甲酰胺作为基于Ro 31-8959的HIV-1蛋白酶抑制剂的新型P-配体
Bioorg Med Chem Lett. 1995 Jan 5;5(1):83-88. doi: 10.1016/0960-894X(94)00463-P. Epub 2000 Mar 29.
4
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.1型人类免疫缺陷病毒的病毒背景在对蛋白酶抑制剂耐药性的产生中起主要作用。
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1648-53. doi: 10.1073/pnas.93.4.1648.
5
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4096-100. doi: 10.1073/pnas.91.9.4096.
6
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.对一种对氨基二醇蛋白酶抑制剂敏感性降低的1型人类免疫缺陷病毒变体的特性分析。
J Virol. 1995 Apr;69(4):2148-52. doi: 10.1128/JVI.69.4.2148-2152.1995.
7
Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.氨基二醇抑制剂对人类免疫缺陷病毒及蛋白酶的抗病毒特性。
Antimicrob Agents Chemother. 1995 Feb;39(2):374-9. doi: 10.1128/AAC.39.2.374.
8
Affinity-based separations and purifications. Patents and literature.基于亲和力的分离与纯化。专利与文献。
Appl Biochem Biotechnol. 1991 Jan;27(1):93-109. doi: 10.1007/BF02921518.
9
Production of cytotoxic proteins in Escherichia coli: a fermentation process for producing enzymatically active HIV-1 protease.大肠杆菌中细胞毒性蛋白的产生:一种生产具有酶活性的HIV-1蛋白酶的发酵工艺。
Appl Microbiol Biotechnol. 1991 Nov;36(2):149-52. doi: 10.1007/BF00164410.
10
Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases.合成“界面”肽改变HIV - 1和HIV - 2蛋白酶的二聚体组装。
Protein Sci. 1992 Oct;1(10):1244-53. doi: 10.1002/pro.5560011003.